isavuconazonium sulfate
FDA approves new anti-fungal treatment
March 9, 2015Sales and Marketing Astellas, Basilea, FDA, US, cresemba, isavuconazonium sulfate, zygomycosis
The FDA has given the OK to Astellas and Basilea for their new treatment in adults with a rare but …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
